Harvard Apparatus Regenerative Technology Inc. (HRGN)
OTCMKTS · Delayed Price · Currency is USD
1.677
-0.003 (-0.15%)
At close: Mar 19, 2026

HRGN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.87-7.73-8.95-6.07-7.98
Depreciation & Amortization
0.10.170.130.070.11
Stock-Based Compensation
2.012.43.461.030.98
Other Operating Activities
----0-0.42
Change in Accounts Receivable
0.22-0.23-0--
Change in Inventory
0.06-0.03-0.05--
Change in Accounts Payable
00.01-0.240.010.65
Change in Unearned Revenue
0.25----
Change in Other Net Operating Assets
0.40.56-1.3-0.144.04
Operating Cash Flow
-3.83-4.85-6.94-5.11-2.63
Capital Expenditures
---0.01-0.01-
Investing Cash Flow
---0.01-0.01-
Short-Term Debt Issued
-0.5---
Total Debt Issued
-0.5---
Short-Term Debt Repaid
--0.5---
Total Debt Repaid
--0.5---
Issuance of Common Stock
2.76.916.145.062.84
Financing Cash Flow
2.76.916.145.062.84
Foreign Exchange Rate Adjustments
-0.01-0.01---
Net Cash Flow
-1.132.05-0.81-0.050.22
Free Cash Flow
-3.83-4.85-6.95-5.11-2.63
Free Cash Flow Margin
-543.75%-1128.37%-6747.57%--
Free Cash Flow Per Share
-0.23-0.33-0.52-0.45-0.26
Cash Interest Paid
0.010.040.010.01-
Levered Free Cash Flow
-1.45-2.36-2.41-6.370.58
Unlevered Free Cash Flow
-1.44-2.34-2.4-6.370.58
Change in Working Capital
0.930.31-1.59-0.144.69
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.